Mark Sabag Insider Trades
See "Remarks"See "Remarks" at Teva Pharmaceutical Industries LTD. 1 significant open-market trade reported on SEC Form 4 in the last 180 days.
On EDGAR, this filer has 39 Form 4 filings on record since 2018, the latest on Nov 6, 2026. Full history on sec.gov
$0
Bought
$1.9M
Sold
0 / 1
Buys / Sells
1
Companies
Companies
- TEVASee "Remarks"
Teva Pharmaceutical Industries LTD
1 sell, $1.9M · 3 alerts in our log
Reported Trades
Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.
| Filed | Company | Trade | Value |
|---|---|---|---|
| Nov 6, 2026 | TEVASee "Remarks" | sell36.3% of stake | $1.9M |
Other Insiders at These Companies
Everyone else who reported a significant open-market trade at the same company in the last 180 days. Several insiders buying at once is cluster buying.
- Dov BergwerkInterim Cheif Legal Officer at TEVA1 sell, $1.1M
- Brian SavageInterim Chief Legal Officer at TEVA1 sell, $285K
- Roberto MignoneDirector at TEVA1 sell, $14.4M
- Amir WeissChief Accounting Officer at TEVA1 sell, $355K
How to Read This Page
These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. The window here is 180 days; the full filing history lives on EDGAR.
Get this insider's next buy when it files
InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.
Try free for 7 daysEvery alert we send is logged with its timestamp and source.